Medtronic, Farapulse Advance Pulsed Field Ablation With US Trials

Two pivotal US trials of pulsed field ablation systems began in early March. Farapulse is sponsoring the ADVENT randomized trial of the Farapulse PFA system and Medtronic launched the international PULSED AF trial of its PulseSelect PFA system.

Farapulse, Inc.’s Farawave PFA catheter
The Tip Of Farapulse's Farawave PFA Catheter In Two Different Configurations • Source: Farapulse

Farapulse and Medtronic expect pulsed field ablation (PFA) technology to eventually dominate the US atrial fibrillation ablation catheter market, but the companies are sponsoring very different US pivotal trials of their respective PFA systems.

PFA creates short, powerful electric pulses that precisely destroy cardiac myocyte cells with irreversible electroporation. Multiple companies are developing PFA systems because preclinical studies and early clinical trials...

More from Clinical Trials

More from R&D